⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8216638 | 0.82 | — | — | |
| SCHEMBL10581606 | 0.82 | — | — | |
| SCHEMBL10583112 | 0.80 | CA1 (0.37) | — | |
| SCHEMBL10582622 | 0.78 | — | — | |
| SCHEMBL10581464 | 0.71 | NOS3 (0.31) | — | |
| SCHEMBL4442495 | 0.71 | — | — | |
| SCHEMBL5186 | 0.69 | — | — | |
| SCHEMBL21764023 | 0.67 | NOS3 (0.31) | — | |
| SCHEMBL12856710 | 0.67 | — | — | |
| SCHEMBL10582979 | 0.67 | TAS1R3 (0.32) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 245 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2888285-B1 | ANTIBODIES TO ARIPIPRAZOLE HAPTENS AND USE THEREOF | JANSSEN PHARMACEUTICA NV (BE) | 2024-04-17 | — | — | EP | disclosed |
| CN-110054694-B | Antibodies to aripiprazole hapten and uses thereof | 詹森药业有限公司 | 2024-02-20 | — | — | CN | disclosed |
| EP-3556759-B1 | HAPTENS OF PALIPERIDONE | JANSSEN PHARMACEUTICA NV (BE) | 2023-11-29 | — | — | EP | disclosed |
| EP-4045095-B1 | IRON (III) COMPLEXES WITH NOVEL CONTRAST PROPERTIES FOR MAGNETIC RESONANCE IMAGING | UNIV BERLIN CHARITE (DE) | 2023-08-02 | — | — | EP | disclosed |
| EP-2888284-B1 | ANTIBODIES TO RISPERIDONE HAPTENS AND USE THEREOF | JANSSEN PHARMACEUTICA NV (BE) | 2022-07-06 | — | — | EP | disclosed |
| CN-109970637-B | Aripiprazole hapten and application thereof in immunoassay | 詹森药业有限公司 | 2022-04-19 | — | — | CN | disclosed |
| CN-108484496-B | Aripiprazole hapten and application thereof in immunoassay | 詹森药业有限公司 | 2022-03-22 | — | — | CN | disclosed |
| US-11225527-B2 | Antibodies to paliperidone haptens and use thereof | JANSSEN PHARMACEUTICA NV (BE) | 2022-01-18 | — | — | US | disclosed |
| US-11226345-B2 | Antibodies to olanzapine haptens and use thereof | JANSSEN PHARMACEUTICA NV (BE) | 2022-01-18 | — | — | US | disclosed |
| EP-3415516-B1 | HAPTENS OF RISPERIDONE AND PALIPERIDONE | JANSSEN PHARMACEUTICA NV (BE) | 2021-12-15 | — | — | EP | disclosed |
| US-4622417-A | DIETETICS | GENERAL FOODS CORPORATION (US) | 1986-11-11 | — | — | US | disclosed |
| US-4622232-A | L-aminodicarboxylic acid alkanes | GENERAL FOODS CORPORATION (US) | 1986-11-11 | — | — | US | disclosed |
| EP-0199257-A2 | L-Aminodicarboxylic acid esters and an edible composition containing same as sweeteners | GENERAL FOODS CORPORATION (US) | 1986-10-29 | — | — | EP | disclosed |
| EP-0199258-A2 | L-Aminodicarboxylic acid amides and an edible composition containing same | GENERAL FOODS CORPORATION (US) | 1986-10-29 | — | — | EP | disclosed |
| US-4619834-A | Sweetening with L-aminodicarboxylic acid aminoalkenoic acid ester amides | GENERAL FOODS CORPORATION (US) | 1986-10-28 | — | — | US | disclosed |
| US-4619782-A | L-aminodicarboxylic acid gem-diamines | GENERAL FOODS CORPORATION (US) | 1986-10-28 | — | — | US | disclosed |
| US-4603012-A | L-aminodicarboxylic acid alkanes | GENERAL FOODS CORPORATION (US) | 1986-07-29 | — | — | US | disclosed |
| EP-0186173-A2 | L-Aminodicarboxylic-(0-cycloalkyl)-L-aminocarboxylate alkyl esters, an edible composition containing same as sweeteners and a method for sweetening an edible composition | GENERAL FOODS CORPORATION (US) | 1986-07-02 | — | — | EP | disclosed |
| US-4572799-A | L-Aminodicarboxylic acid amides | GENERAL FOODS CORPORATION (US) | 1986-02-25 | — | — | US | disclosed |
| US-4571308-A | L-Aminodicarboxylic acid aminoalkenoic acid ester amides | GENERAL FOODS CORPORATION (US) | 1986-02-18 | — | — | US | disclosed |